[BIC-announce] FW: [NEURO] April 26, 2007 Wilder Penfield Lecture at 4:30 pm

[Jennifer Chew, Ms.]

PLEASE DISCARD IF THIS IS A DUPLICATE.  THANK YOU.  JENNIFER  
-----Original Message-----
From: neuro [mailto:NEURO at LISTS.MCGILL.CA] On Behalf Of Sandra McPherson, Dr.
Sent: Friday, April 20, 2007 8:42 AM
To: NEURO at LISTS.MCGILL.CA
Subject: [NEURO] April 26, 2007 Wilder Penfield Lecture at 4:30 pm

Dear Neuro Faculty, Staff, Students and Fellows,

The MNI's named lecturers are prestigious members of the international scientific and business communities or the government. They are chosen with considerable thought for their appeal to The Neuro and the broader academic and medical communities.  

It reflects badly on the MNI when these lectures are poorly attended as was the case for Wednesday's Jerzy Olszewski Lecture by Yale University's Tamas Horvath.  It is embarrassing for the host and disappointing for the speaker.

The 2007 Wilder Penfield Lecture will take place on Thursday, April 26, 2007 at 4:30 p.m. in the Jeanne Timmins Amphitheatre. 

Please make every effort to attend.

Regards,
Sandra McPherson

"Breaking Down Barriers to Advance Health and Medicine"
By Mr. Scott Johnson
President and Founder, Myelin Repair Foundation

Thursday, April 26, 2007 at 4:30 p.m.
Jeanne Timmins Amphitheatre.
A reception will follow the lecture.

Biography
Scott Johnson, President and Founder, Myelin Repair Foundation In 2006, Scientific American named Scott Johnson one of the top 50 leaders in business, science and policy. Four years earlier, Mr. Johnson founded the Myelin Repair Foundation (MRF) to accelerate the rate of discovery leading to treatments for multiple sclerosis (MS), a neurological disease he has had for more than 30 years. To advance this mission, MRF chose five outstanding scientists in North America to participate in a unique collaboration that would create a virtual, cross-continental research group. This group includes Dr. David Colman whose lab at the MNI studies how to repair myelin, a critically important covering on nerve fibres that is damaged by MS.
 
After more than 20 years in business, Mr. Johnson established the MRF to blend the best practices in business with those in academic scientific discovery. This approach has resulted in accelerating basic research on myelin by as much as 200%, and generated enthusiasm for the MRF model that may revolutionize the way medical research is done. Earlier in his career, Mr. Johnson led three startup companies and held executive positions at FMC Corporation and the Boston Consulting Group. He holds an MBA and a BSc in Civil Engineering.